2019
DOI: 10.1016/j.prp.2019.04.011
|View full text |Cite
|
Sign up to set email alerts
|

Circular RNAs as diagnostic biomarkers in gastric cancer: A meta-analysis review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
27
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 26 publications
(27 citation statements)
references
References 32 publications
0
27
0
Order By: Relevance
“…Over the past 3 years, dysregulation of circRNA profiles have been published, as well as the role in GC progression [10,11]. Very recently, circR-NAs have been documented as biomarkers and targets for human cancers including GC [12,13]. Since the stability of circRNAs is higher than linear splicing products such as miRNAs, long noncoding RNAs and mRNAs, cir-cRNAs could be a promising potential biomarkers [10].…”
Section: Introductionmentioning
confidence: 99%
“…Over the past 3 years, dysregulation of circRNA profiles have been published, as well as the role in GC progression [10,11]. Very recently, circR-NAs have been documented as biomarkers and targets for human cancers including GC [12,13]. Since the stability of circRNAs is higher than linear splicing products such as miRNAs, long noncoding RNAs and mRNAs, cir-cRNAs could be a promising potential biomarkers [10].…”
Section: Introductionmentioning
confidence: 99%
“…4 Moreover, previous research has indicated that circRNAs could serve as pivotal targets for the diagnosis and development of gastric cancer. 5 For example, circRNA proteasome subunit C3 (circPSMC3), hsa_circ_0001368 and protein kinase B3 (circAKT3) have been reported to act as competing endogenous RNAs (ceRNAs) to promote or inhibit gastric cancer progression by regulating proliferation, metastasis and drug resistance. [6][7][8] As for circRNA nuclear receptor interacting protein 1 (circNRIP1), a novel circRNAs exhibits a promoting role in the development of gastric cancer.…”
Section: Introductionmentioning
confidence: 99%
“…Various up- or downregulated circRNAs have been reported in GC tissues [ 86 ]. Because of their abundance, stability, tissue-specific expression, and broad circulation in diverse body fluids and exosomes, circRNAs could be new diagnostic biomarkers and GC therapeutic targets [ 87 ]. CircRNAs derived from exosomes (ex-circRNAs) could be a new diagnostic and/or prognostic marker.…”
Section: Circular Rnas (Circrnas)mentioning
confidence: 99%